Cargando…

Antifungal Treatments Delineate a Correlation between Cathepsins and Cytokines in Murine Model of Invasive Aspergillosis

In the pathogenesis of invasive pulmonary aspergillosis both fungal and host factors play roles. Though cytokines and phagocyte, as host factors, have been shown to participate in defence against Aspergillus species yet the role of cysteine proteases, that is cathepsins, a lysosomal enzymes of phago...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mittal, Ashwani, Gahlaut, Anjum, Sharma, G. L., Dabur, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928733/ https://www.ncbi.nlm.nih.gov/pubmed/24591744

Ejemplares similares

Nontargeted Identification of the Phenolic and Other Compounds of Saraca asoca by High Performance Liquid Chromatography-Positive Electrospray Ionization and Quadrupole Time-of-Flight Mass Spectrometry
por: Mittal, Ashwani, et al.
Publicado: (2013)

Quantitative analysis of catechins in Saraca asoca and correlation with antimicrobial activity
por: Shirolkar, Amey, et al.
Publicado: (2013)

β-sitosterol in different parts of Saraca asoca and herbal drug ashokarista: Quali-quantitative analysis by liquid chromatography-mass spectrometry
por: Gahlaut, Anjum, et al.
Publicado: (2013)

In Vivo Efficacy of a Synthetic Coumarin Derivative in a Murine Model of Aspergillosis
por: Singh, Seema, et al.
Publicado: (2014)

SCY-078 Demonstrates Significant Antifungal Activity in a Murine Model of Invasive Aspergillosis
por: Borroto-Esoda, Katyna, et al.
Publicado: (2017)

Modeling Invasive Aspergillosis: How Close Are Predicted Antifungal Targets?
por: Walsh, Thomas J., et al.
Publicado: (2020)

APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2019)

Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management
por: Rudramurthy, Shivaprakash M., et al.
Publicado: (2019)

TREM1 regulates antifungal immune responses in invasive pulmonary aspergillosis
por: Bernal-Martínez, L, et al.
Publicado: (2021)

A Tet-Off gene expression system for validation of antifungal drug targets in a murine invasive pulmonary aspergillosis model
por: Peng, Yutian, et al.
Publicado: (2018)

GR-2397: Review of the Novel Siderophore-like Antifungal Agent for the Treatment of Invasive Aspergillosis
por: Shaw, Karen Joy
Publicado: (2022)

Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature
por: Mayr, A, et al.
Publicado: (2011)

Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis
por: Lee, Dong‐Gun, et al.
Publicado: (2019)

Efficacy of Ebselen Against Invasive Aspergillosis in a Murine Model
por: Sakita, Karina Mayumi, et al.
Publicado: (2021)

Potential antifungal targets based on histones post-translational modifications against invasive aspergillosis
por: Li, Yiman, et al.
Publicado: (2022)

Molecular epidemiology and antifungal susceptibilities of Aspergillus species isolated from patients with invasive aspergillosis
por: Sarigüzel, Fatma Mutlu, et al.
Publicado: (2023)

Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis
por: Neofytos, Dionysios, et al.
Publicado: (2015)

Combination antifungal therapy and surgery for the treatment of invasive pulmonary aspergillosis after hematopoietic stem cell transplantation
por: Cesaro, Simone, et al.
Publicado: (2011)

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis()
por: Denning, David W., et al.
Publicado: (2006)

COVID Associated Invasive Aspergillosis
por: Bhandari, Sudhir, et al.
Publicado: (2022)

Vaccine-Induced Protection in Two Murine Models of Invasive Pulmonary Aspergillosis
por: Rayens, Emily, et al.
Publicado: (2021)

Genetic Variation in PFKFB3 Impairs Antifungal Immunometabolic Responses and Predisposes to Invasive Pulmonary Aspergillosis
por: Gonçalves, Samuel M., et al.
Publicado: (2021)

Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis
por: Allan, Euan Ramsay Orr, et al.
Publicado: (2015)

Cytokine and Chemokine Responses in Invasive Aspergillosis Following Hematopoietic Stem Cell Transplantation: Past Evidence for Future Therapy of Aspergillosis
por: Thammasit, Patcharin, et al.
Publicado: (2021)

Clinical and Pathological Correlation in Pediatric Invasive Pulmonary Aspergillosis
por: Anantasit, Nattachai, et al.
Publicado: (2018)

Are We There Yet? Recent Progress in the Molecular Diagnosis and Novel Antifungal Targeting of Aspergillus fumigatus and Invasive Aspergillosis
por: Steinbach, William J.
Publicado: (2013)

Invasive Pulmonary Aspergillosis in Acute-on-Chronic Liver Failure Patients: Short-Term Outcomes and Antifungal Options
por: Chen, Danli, et al.
Publicado: (2021)

Antifungal Siderophore Conjugates for Theranostic Applications in Invasive Pulmonary Aspergillosis Using Low-Molecular TAFC Scaffolds
por: Pfister, Joachim, et al.
Publicado: (2021)

Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis
por: Ghannoum, M., et al.
Publicado: (2018)

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
por: Wiederhold, Nathan P, et al.
Publicado: (2009)

Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis
por: Hawes, Armani M., et al.
Publicado: (2022)

Pediatric Invasive Aspergillosis
por: Wattier, Rachel L., et al.
Publicado: (2016)

Invasive Pulmonary Aspergillosis
por: Ledoux, Marie-Pierre, et al.
Publicado: (2023)

Evaluation of Bronchoalveolar Lavage Fluid Cytokines as Biomarkers for Invasive Pulmonary Aspergillosis in At-Risk Patients
por: Gonçalves, Samuel M., et al.
Publicado: (2017)

Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets
por: Russo, Alessandro, et al.
Publicado: (2022)

Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States
por: Durden, Emily, et al.
Publicado: (2013)

Invasive aspergillosis successfully treated by combined antifungal therapy and immunosuppressive monotherapy two months following heart transplantation
por: Urbanowicz, Tomasz, et al.
Publicado: (2016)

Use of Antifungals and Outcomes Among Inpatients at Risk of Invasive Aspergillosis or Mucormycosis in the USA: A Retrospective Cohort Study
por: Stull, Katherine, et al.
Publicado: (2019)

Impact of the SARS-CoV-2 Pandemic in Candidaemia, Invasive Aspergillosis and Antifungal Consumption in a Tertiary Hospital
por: Mulet Bayona, Juan Vicente, et al.
Publicado: (2021)

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
por: Grau, Santiago, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u0f1id68qva0htghhgi9eq97en